Isomer-Resolved Imaging of Prostate Cancer Tissues Reveals Specific Lipid Unsaturation Profiles Associated With Lymphocytes and Abnormal Prostate Epithelia.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 01 04 2021
accepted: 29 06 2021
entrez: 23 8 2021
pubmed: 24 8 2021
medline: 24 12 2021
Statut: epublish

Résumé

Prostate cancer is the fourth most common cancer worldwide with definitive diagnosis reliant on biopsy and human-graded histopathology. As with other pathologies, grading based on classical haematoxylin and eosin (H&E) staining of formalin fixed paraffin-embedded material can be prone to variation between pathologists, prompting investigation of biomolecular markers. Comprising around 50% of cellular mass, and with known metabolic variations in cancer, lipids provide a promising target for molecular pathology. Here we apply isomer-resolved lipidomics in combination with imaging mass spectrometry to interrogate tissue sections from radical prostatectomy specimens. Guided by the histopathological assessment of adjacent tissue sections, regions of interest are investigated for molecular signatures associated with lipid metabolism, especially desaturation and elongation pathways. Monitoring one of the most abundant cellular membrane lipids within these tissues, phosphatidylcholine (PC) 34:1, high positive correlation was observed between the n-9 isomer (site of unsaturation 9-carbons from the methyl terminus) and epithelial cells from potential pre-malignant lesions, while the n-7 isomer abundance was observed to correlate with immune cell infiltration and inflammation. The correlation of lipid isomer signatures with human disease states in tissue suggests a future role for isomer-resolved mass spectrometry imaging in assisting pathologists with prostate cancer diagnoses and patient stratification.

Identifiants

pubmed: 34421820
doi: 10.3389/fendo.2021.689600
pmc: PMC8374165
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

689600

Informations de copyright

Copyright © 2021 Young, Claes, Bowman, Williams, Shepherd, Perren, Poad, Ellis, Heeren, Sadowski and Blanksby.

Déclaration de conflit d'intérêts

S.J.B. holds patents on ozone-induced dissociation technology (A method for the determination of the position of unsaturation in a compound, US8242439 and US7771943). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Metab. 2019 Aug;1(8):745-747
pubmed: 32694765
Cell. 2008 Sep 19;134(6):933-44
pubmed: 18805087
Analyst. 2014 Jan 7;139(1):204-14
pubmed: 24244938
BJU Int. 2018 Dec;122(6):946-958
pubmed: 29679430
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2573-8
pubmed: 26903636
Anal Chem. 2021 Jul 20;93(28):9826-9834
pubmed: 34228922
Anal Chem. 1999 May 15;71(10):1981-9
pubmed: 10361497
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Cell Rep. 2021 Feb 9;34(6):108738
pubmed: 33567271
Anal Bioanal Chem. 2020 Oct;412(25):6875-6886
pubmed: 32712813
Am J Surg Pathol. 2019 Mar;43(3):361-368
pubmed: 30531531
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nat Methods. 2018 Jul;15(7):515-518
pubmed: 29786091
Cancer Res. 2019 Oct 15;79(20):5355-5366
pubmed: 31270077
Anal Chem. 2008 Jan 1;80(1):303-11
pubmed: 18062677
Mass Spectrom Rev. 2000 Nov-Dec;19(6):398-420
pubmed: 11199379
Chem Soc Rev. 2014 Apr 21;43(8):2757-83
pubmed: 24481009
Oncotarget. 2015 Mar 30;6(9):7348-63
pubmed: 25749516
Eur J Cancer. 2005 Jun;41(9):1316-22
pubmed: 15869874
Anal Chem. 2019 Mar 5;91(5):3575-3581
pubmed: 30702282
J Am Soc Mass Spectrom. 1991 Apr;2(2):180-3
pubmed: 24242180
BJU Int. 2003 Dec;92 Suppl 2:62-5
pubmed: 14983958
J Anal Toxicol. 2021 Feb 6;45(1):76-83
pubmed: 32248226
Anal Chem. 2020 Feb 18;92(4):3133-3142
pubmed: 31955581
Cell Chem Biol. 2016 Jun 23;23(6):689-99
pubmed: 27265749
Anal Chem. 2017 Apr 4;89(7):4223-4229
pubmed: 28252928
Prog Lipid Res. 2010 Apr;49(2):186-99
pubmed: 20018209
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Cell Stem Cell. 2017 Mar 2;20(3):303-314.e5
pubmed: 28041894
Angew Chem Int Ed Engl. 2018 Aug 13;57(33):10530-10534
pubmed: 29787633
J Lipid Res. 2016 Apr;57(4):638-49
pubmed: 26891736
Sci Rep. 2018 Apr 26;8(1):6586
pubmed: 29700319
J Lipid Res. 2018 Feb;59(2):237-249
pubmed: 29167413
Chem Rev. 2010 May 12;110(5):3237-77
pubmed: 20423155
Cancer Res. 2021 Apr 1;81(7):1704-1718
pubmed: 33547161
Mol Cancer Ther. 2010 Jun;9(6):1740-54
pubmed: 20530718
Anal Chem. 2016 Sep 20;88(18):8931-5
pubmed: 27560604
Hypertension. 2001 Feb;37(2):308-12
pubmed: 11230290
Nucleic Acids Res. 2007 Jan;35(Database issue):D527-32
pubmed: 17098933
Analyst. 2016 Jun 21;141(12):3832-41
pubmed: 27041214
Ann Intern Med. 2010 Dec 21;153(12):790-9
pubmed: 21173413
BJU Int. 2012 Jun;109(11):1636-47
pubmed: 22077593
Clin Cancer Res. 2013 May 1;19(9):2368-80
pubmed: 23633458

Auteurs

Reuben S E Young (RSE)

School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD, Australia.

Britt S R Claes (BSR)

M4I, The Maastricht MultiModal Molecular Imaging Institute, Division of Imaging Mass Spectrometry, Maastricht University, Maastricht, Netherlands.

Andrew P Bowman (AP)

M4I, The Maastricht MultiModal Molecular Imaging Institute, Division of Imaging Mass Spectrometry, Maastricht University, Maastricht, Netherlands.

Elizabeth D Williams (ED)

Australian Prostate Cancer Research Centre - Queensland, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD, Australia.

Benjamin Shepherd (B)

Department of Pathology, Princess Alexandra Hospital, Brisbane, QLD, Australia.

Aurel Perren (A)

Institute of Pathology, University of Bern, Bern, Switzerland.

Berwyck L J Poad (BLJ)

School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD, Australia.
Central Analytical Research Facility, Queensland University of Technology, Brisbane, QLD, Australia.

Shane R Ellis (SR)

M4I, The Maastricht MultiModal Molecular Imaging Institute, Division of Imaging Mass Spectrometry, Maastricht University, Maastricht, Netherlands.
Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia.
Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia.

Ron M A Heeren (RMA)

M4I, The Maastricht MultiModal Molecular Imaging Institute, Division of Imaging Mass Spectrometry, Maastricht University, Maastricht, Netherlands.

Martin C Sadowski (MC)

Australian Prostate Cancer Research Centre - Queensland, Faculty of Health, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD, Australia.
Institute of Pathology, University of Bern, Bern, Switzerland.

Stephen J Blanksby (SJ)

School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD, Australia.
Central Analytical Research Facility, Queensland University of Technology, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH